|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 546 | 1 | 0.2 | 375 | 68.7 | 100 | 18.3 | 54 | 9.9 | 16 | 2.9 |
| 2015-2019 | 576 | 1 | 0.2 | 391 | 67.9 | 110 | 19.1 | 57 | 9.9 | 17 | 3.0 |
| 2014-2018 | 582 | 1 | 0.2 | 399 | 68.6 | 109 | 18.7 | 53 | 9.1 | 20 | 3.4 |
| 2013-2017 | 578 | 1 | 0.2 | 399 | 69.0 | 105 | 18.2 | 50 | 8.7 | 23 | 4.0 |
| 2012-2016 | 610 | 1 | 0.2 | 450 | 73.8 | 96 | 15.7 | 40 | 6.6 | 23 | 3.8 |
| 2011-2015 | 658 | - | - | 497 | 75.5 | 96 | 14.6 | 35 | 5.3 | 30 | 4.6 |
| 2010-2014 | 644 | - | - | 496 | 77.0 | 86 | 13.4 | 29 | 4.5 | 33 | 5.1 |
| 2009-2013 | 669 | - | - | 532 | 79.5 | 83 | 12.4 | 22 | 3.3 | 32 | 4.8 |
| 2008-2012 | 702 | - | - | 574 | 81.8 | 75 | 10.7 | 21 | 3.0 | 32 | 4.6 |
| 2007-2011 | 718 | - | - | 589 | 82.0 | 76 | 10.6 | 20 | 2.8 | 33 | 4.6 |
| 2006-2010 | 717 | - | - | 605 | 84.4 | 63 | 8.8 | 21 | 2.9 | 28 | 3.9 |
| 2005-2009 | 793 | - | - | 682 | 86.0 | 62 | 7.8 | 22 | 2.8 | 27 | 3.4 |
| 2004-2008 | 794 | - | - | 674 | 84.9 | 62 | 7.8 | 25 | 3.1 | 33 | 4.2 |
| 2003-2007 | 836 | - | - | 705 | 84.3 | 65 | 7.8 | 23 | 2.8 | 43 | 5.1 |
| 2002-2006 | 885 | - | - | 753 | 85.1 | 62 | 7.0 | 20 | 2.3 | 50 | 5.6 |
| 2001-2005 | 889 | - | - | 743 | 83.6 | 68 | 7.6 | 16 | 1.8 | 62 | 7.0 |
| 2000-2004 | 890 | - | - | 739 | 83.0 | 69 | 7.8 | 17 | 1.9 | 65 | 7.3 |
| 1999-2003 | 902 | - | - | 737 | 81.7 | 65 | 7.2 | 16 | 1.8 | 84 | 9.3 |
| 1998-2002 | 883 | - | - | 683 | 77.3 | 66 | 7.5 | 17 | 1.9 | 117 | 13.3 |
| 1997-2001 | 833 | - | - | 614 | 73.7 | 68 | 8.2 | 16 | 1.9 | 135 | 16.2 |
| 1996-2000 | 795 | - | - | 563 | 70.8 | 66 | 8.3 | 20 | 2.5 | 146 | 18.4 |
| 1995-1999 | 716 | - | - | 468 | 65.4 | 65 | 9.1 | 19 | 2.7 | 164 | 22.9 |
| 1994-1998 | 702 | 2 | 0.3 | 426 | 60.7 | 62 | 8.8 | 18 | 2.6 | 194 | 27.6 |
| 1993-1997 | 698 | 4 | 0.6 | 391 | 56.0 | 64 | 9.2 | 31 | 4.4 | 208 | 29.8 |
| 1992-1996 | 738 | 5 | 0.7 | 385 | 52.2 | 70 | 9.5 | 41 | 5.6 | 237 | 32.1 |
| 1991-1995 | 777 | 6 | 0.8 | 398 | 51.2 | 72 | 9.3 | 39 | 5.0 | 262 | 33.7 |
| 1990-1994 | 814 | 6 | 0.7 | 369 | 45.3 | 66 | 8.1 | 38 | 4.7 | 335 | 41.2 |
| 1989-1993 | 773 | 5 | 0.6 | 316 | 40.9 | 62 | 8.0 | 40 | 5.2 | 350 | 45.3 |
| 1988-1992 | 714 | 3 | 0.4 | 311 | 43.6 | 50 | 7.0 | 31 | 4.3 | 319 | 44.7 |
| 1987-1991 | 646 | 6 | 0.9 | 295 | 45.7 | 33 | 5.1 | 24 | 3.7 | 288 | 44.6 |
| 1986-1990 | 575 | 5 | 0.9 | 267 | 46.4 | 28 | 4.9 | 25 | 4.3 | 250 | 43.5 |
| 1985-1989 | 518 | 5 | 1.0 | 295 | 56.9 | 25 | 4.8 | 25 | 4.8 | 168 | 32.4 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |